VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

Therapy Areas

General Surgery & Minimally Invasive Devices

Strategic insight for surgical innovation

Overview

BSC supports surgical device development across general surgery, including laparoscopic systems, robotic surgery platforms, surgical staplers and sealants, energy-based devices, and surgical navigation systems. Our experience spans both open and minimally invasive surgical techniques.

Specialized Capabilities

Surgical outcome composite endpoint design. Handling of surgeon learning curves in statistical models. Non-inferiority designs for surgical device equivalence. Complication rate analysis with appropriate risk adjustment. Economic endpoint integration (length of stay, resource utilization).

Regulatory Experience

We understand FDA expectations for surgical devices, including appropriate concurrent controls, handling of surgeon variability, and demonstration of device safety across skill levels. Our team has experience with both substantial equivalence (510(k)) and PMA pathways.

Representative Studies

  • Laparoscopic and robotic surgical systems.

  • Surgical staplers and closure devices.

  • Energy-based surgical devices (electrosurgery, ultrasonic).

  • Surgical mesh and fixation products.

  • Surgical navigation and guidance systems.

Design

We use innovative approaches Bayesian design, adaptive clinical trial design, and Propensity Score Matching to reduce costs, overcome limited data access, and minimize bias in non-randomized studies.

Analyze

Advance

Testimonials

See what our sponsors say about BSC®

On Experience

“Battle ground tested.”

“There is nothing that David and team haven’t seen over the years – the good, bad, and ugly.”

• Vice President, Clinical Operations

• Former FDA Regulator

• CEO, Medical Device Company

Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.